Current and future treatment options for esophageal cancer in the elderly

被引:179
作者
Bollschweiler, Elfriede [1 ]
Plum, Patrick [1 ]
Moenig, Stefan P. [1 ,2 ]
Hoelscher, Arnulf H. [1 ,3 ]
机构
[1] Univ Cologne, Dept Gen Visceral & Canc Surg, Lindauer Str 63, D-50935 Cologne, Germany
[2] Hop Univ Geneve, Serv Chirurg, Geneva, Switzerland
[3] AGAPLESION Markus Krankenhaus, Dept Surg, Frankfurt, Germany
关键词
Esophageal cancer; elderly patients; esophagectomy; neoadjuvant therapy; chemotherapy; chemoradiation; SQUAMOUS-CELL CARCINOMA; LONG-TERM SURVIVAL; NEOADJUVANT CHEMORADIATION; PERIOPERATIVE CHEMOTHERAPY; RESECTABLE ESOPHAGEAL; HISTOPATHOLOGIC RESPONSE; ESOPHAGOGASTRIC CANCER; ENDOSCOPIC MANAGEMENT; BARRETTS-ESOPHAGUS; PROGNOSTIC IMPACT;
D O I
10.1080/14656566.2017.1334764
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Introduction: Esophageal cancer is the eighth most common cancer globally and has the sixth worst prognosis because of its aggressiveness and poor survival. Data regarding cancer treatment in older patients is limited because the elderly have been under-represented in clinical trials. Therefore, we reviewed the existing literature regarding treatment results for elderly patients (70+ years).Areas covered: We used pubmed to analyze the actual literature according to elderly esophageal cancer patients with subheading of incidence, esophagectomy, chemoradiation or chemotherapy. The main points of interest were treatment options for patients with Barrett's esophagus or early carcinoma, advanced tumor stages, and inoperable cancer.Expert opinion: The incidence of esophageal cancer has been increasing over the past thirty years, with a rapid increase of esophageal adenocarcinoma in Western industrialized nations. Patients aged over 60years have been particularly affected. In this review, we have shown that elderly patients with esophageal cancer have various alternatives for adequate treatment. Clinical evaluation of comorbidity is necessary to make treatment decisions. Therapeutic options for early carcinomas are endoscopic or surgical resection. For elderly patients with advanced carcinomas, preoperative chemoradiation or chemotherapy should be discussed.
引用
收藏
页码:1001 / 1010
页数:10
相关论文
共 80 条
[1]
The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: A randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+) [J].
Al-Batran, Salah-Eddin ;
Pauligk, Claudia ;
Homann, Nils ;
Hartmann, Joerg T. ;
Moehler, Markus ;
Probst, Stephan ;
Rethwisch, Volker ;
Stoehlmacher-Williams, Jan ;
Prasnikar, Nicole ;
Hollerbach, Stephan ;
Bokemeyer, Carsten ;
Mahlberg, Rolf ;
Hofheinz, Ralf D. ;
Luley, Kim ;
Kullmann, Frank ;
Jaeger, Elke .
EUROPEAN JOURNAL OF CANCER, 2013, 49 (04) :835-842
[2]
Neoadjuvant chemotherapy for resectable oesophageal and junctional adenocarcinoma: Results from the UK Medical Research Council randomised OEO5 trial (ISRCTN 01852072) [J].
Alderson, Derek ;
Langley, Ruth E. ;
Nankivell, Matthew Guy ;
Blazeby, Jane M. ;
Griffin, Michael ;
Crellin, Adrian ;
Grabsch, Heike I. ;
Okines, Alicia Frances Clare ;
Goldstein, Cindy ;
Falk, Stephen ;
Thompson, Joyce ;
Krysztopik, Richard ;
Coxon, Fareeda Y. ;
Pritchard, Susan ;
Langer, Rupert ;
Stenning, Sally Patricia ;
Cunningham, David .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[3]
Long-Term Results of a Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal Cancer [J].
Allum, William H. ;
Stenning, Sally P. ;
Bancewicz, John ;
Clark, Peter I. ;
Langley, Ruth E. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (30) :5062-5067
[4]
[Anonymous], ASTRON TELEGRAM
[5]
Global incidence of oesophageal cancer by histological subtype in 2012 [J].
Arnold, Melina ;
Soerjomataram, Isabelle ;
Ferlay, Jacques ;
Forman, David .
GUT, 2015, 64 (03) :381-387
[6]
Systemic treatment of gastric and esophageal adenocarcinoma in elderly patients [J].
Balducci, Lodovico .
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2015, 6 (01) :75-78
[7]
Studying Cancer Treatment in the Elderly Patient Population [J].
Balducci, Lodovico .
CANCER CONTROL, 2014, 21 (03) :215-220
[8]
Bancewicz J, 2002, LANCET, V359, P1727
[9]
Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial [J].
Biere, Surya S. A. Y. ;
Henegouwen, Mark I. van Berge ;
Maas, Kirsten W. ;
Bonavina, Luigi ;
Rosman, Camiel ;
Roig Garcia, Josep ;
Gisbertz, Suzanne S. ;
Klinkenbijl, Jean H. G. ;
Hollmann, Markus W. ;
de lange, Elly S. M. ;
Bonjer, H. Jaap ;
van der Peet, Donald L. ;
Cuesta, Miguel A. .
LANCET, 2012, 379 (9829) :1887-1892
[10]
Bollschweiler E, 2001, CANCER, V92, P549, DOI 10.1002/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO